|
|
- IRMS - Nicolae Testemitanu SUMPh
- 1. COLECȚIA INSTITUȚIONALĂ
- MedEspera: International Medical Congress for Students and Young Doctors
- MedEspera 2026
Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12710/33904
| Title: | ASSESSMENT OF RISK FACTORS ASSOCIATED WITH THE ADULTERATION OF DIETARY SUPPLEMENTS |
| Authors: | Pelivan, Alexia |
| Keywords: | Dietary supplements;adulteration;risk factors;quality control;product safety |
| Issue Date: | 2026 |
| Publisher: | Centrul Editorial-Poligrafic Medicina |
| Citation: | Pelivan, Alexia. ASSESSMENT OF RISK FACTORS ASSOCIATED WITH THE ADULTERATION OF DIETARY SUPPLEMENTS. In: MedEspera 2026, p. 84. ISBN 978-9975-82-486-6. |
| Abstract: | Introduction. The rapid expansion of the dietary supplement market has been accompanied by an increasing number of reported cases of adulteration, involving the addition of undeclared substances, substitution of ingredients, or contamination with potentially toxic compounds. Such practices compromise product authenticity and may pose significant risks to public health, including adverse reactions and drug-supplement interactions. Aim of study. To identify and evaluate the main risk factors involved in the adulteration of dietary supplements and the analytical methods used for their detection. Methods and materials. A systematic analysis of the scientific literature was conducted using the databases PubMed, Scopus, ScienceDirect, and Web of Science, complemented by reports from regulatory authorities (FDA, EFSA). A total of 72 publications published between 2015 and 2024 were analyzed. Inclusion criteria comprised original research articles, official reports, and review papers documenting cases of adulteration or methods used for their detection. Articles lacking experimental data, duplicate publications, and studies that did not directly address the composition or authenticity of dietary supplements were excluded. Results. The literature analysis showed that 58% of the reviewed studies reported adulteration through the addition of undeclared pharmacologically active substances, particularly in supplements marketed for weight loss, sports performance, and sexual enhancement. Thirty-four percent of the sources indicated contamination with heavy metals, pesticides, or microorganisms, while 27% reported substitution of plant raw materials with non-authentic or lower-quality species. The identified risk factors included economic pressure and market competition (42% of studies), lack of traceability of raw materials (38%), insufficient manufacturing control (33%), and unauthorized online marketing (29%). Analytical methods used to detect adulteration included chromatographic techniques (HPLC, GC-MS) reported in 61% of the studies, mass spectrometry (54%), and molecular methods for botanical authentication (DNA barcoding, 23%). Conclusions. Adulteration of dietary supplements is primarily associated with the introduction of undeclared pharmacologically active substances and with deficiencies in raw material traceability. Chromatographic and spectrometric techniques represent the main analytical tools for detecting these practices. Strengthening quality control systems, improving supply chain monitoring, and developing rapid analytical screening methods are essential measures for reducing risks to consumers. |
| metadata.dc.relation.ispartof: | MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026 |
| URI: | https://medespera.md/documents/abstract-book-4.pdf https://repository.usmf.md/handle/20.500.12710/33904 |
| ISBN: | 978-9975-82-486-6 |
| Appears in Collections: | MedEspera 2026
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|